Gapping up
In reaction to strong earnings/guidance:
- MDCA +29.1%, ASUR +16.4%, CATS +15.7%, AVID +8.4%, HTHT +7.3%, TRQ +5.9%, ULTA +5.4%, AVGO +5%, CTRN +2.6%, LTS +2.1%, MRAM +1.3%, JBL +0.7%, TERP +0.7%
M&A news:
- BIOS +23.2% (Bioscrip and Option Care Enterprises announce definitive merger agreement)
Other news:
- KPTI +18.2% (announces FDA extension of review period for selinexor New Drug Application; PDUFA action date extended by three months to July 6, 2019)
- YTRA +8% (entered into a mutual confidentiality agreement with Ebix (EBIX) in regards to Ebix's proposal made on March 11, 2019 to acquire the co)
- ADMP +6.4% (announces FDA acceptance of NDA for its higher dose naloxone injection product candidate )
- ORGO +5% (announced new $100 million credit agreement with Silicon Valley Bank and MidCap Financial)
- GNW +3.9% (Genworth Financial and Oceanwide extend merger agreement)
- NWL +2.4% (announces retirement of CEO Michael Polk, effective at the end of the second quarter)
- HIIQ +1.4% (expands common stock repurchase authorization by additional $100 mln)
Analyst comments:
- RCII +2.1% (upgraded to Outperform from Mkt Perform at Raymond James)
- CFX +1.7% (upgraded to Equal Weight from Underweight at Barclays)
- AMZN +1.2% (upgraded to Overweight from Sector Weight at KeyBanc Capital Markets)
- T +1.1% (upgraded to Outperform from Mkt Perform at Raymond James)